The manufacturer of captobact linezolid is Macleods Pharmaceuticals Limited [1].
Who else makes linezolid?
Linezolid is an antibiotic used to treat serious infections caused by certain bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Several companies manufacture linezolid. In addition to Macleods Pharmaceuticals Limited, other manufacturers include Pfizer Inc., which originally developed and marketed the drug under the brand name Zyvox [2]. Numerous generic versions of linezolid are also available from various pharmaceutical companies worldwide.
What is Captobact used for?
Captobact, containing the active ingredient linezolid, is prescribed to treat infections such as pneumonia, skin and soft tissue infections, and vancomycin-resistant Enterococcus faecium infections [2]. It is effective against Gram-positive bacteria [3].
How does linezolid work?
Linezolid is an oxazolidinone antibiotic. It works by inhibiting bacterial protein synthesis, a crucial process for bacterial survival and replication. It binds to the 50S ribosomal subunit of bacteria, preventing the formation of the initiation complex necessary for protein production [3].
When does linezolid patent protection end?
The original patent for linezolid (Zyvox) has expired, allowing for the manufacturing of generic versions. Patent expiry dates can vary by region and may involve specific formulation or method-of-use patents that could extend market exclusivity for certain applications. Information on specific patent statuses and expiry dates for linezolid can be found through resources like DrugPatentWatch.com [4].
What are the side effects of linezolid?
Common side effects of linezolid can include diarrhea, nausea, headache, and rash [2]. More serious side effects, although less common, can include bone marrow suppression (leading to low platelet, white blood cell, or red blood cell counts), lactic acidosis, and peripheral or optic neuropathy, especially with prolonged use [3]. Patients are advised to discuss potential side effects and risks with their healthcare provider.
Are there alternatives to linezolid?
Treatment options for Gram-positive bacterial infections depend on the specific type of infection, the bacteria involved, and the patient's medical condition. Alternatives to linezolid may include other classes of antibiotics such as vancomycin, daptomycin, clindamycin, or ceftaroline, depending on the susceptibility of the infecting organism and the clinical situation [3].
How is linezolid administered?
Linezolid can be administered intravenously (IV) or orally, depending on the formulation and the patient's condition. The choice between IV and oral administration is typically based on the severity of the infection and the ability of the patient to take oral medications [2].
Sources:
1. https://www.drugpatentwatch.com/
2. https://www.ncbi.nlm.nih.gov/books/NBK540070/
3. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=90f63f45-578e-4015-8421-9a60b4304042
4. Information available via DrugPatentWatch.com subscription services regarding specific patent timelines.